MedTrace Logo

Expanded NIPT for Pregnancy Complications

NCT04311749 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 70

Last updated 2024-10-18

No results posted yet for this study

Summary

This study evaluates the utility of expanded panel non-invasive prenatal testing (NIPT) in detecting confined placental mosaicism of rare autosomal trisomies among pregnancies with placentally-mediated complications, including fetal growth restriction and severe preeclampsia.

Conditions

  • Fetal Growth Restriction
  • Preeclampsia Severe

Interventions

GENETIC

Expanded panel cell free DNA testing (non-invasive prenatal testing)

Maternal blood sampling

GENETIC

Placental biopsy

Post-delivery placental sampling

GENETIC

Umbilical cord blood

Post-delivery umbilical cord blood sampling

Sponsors & Collaborators

Principal Investigators

  • Nasim Sobhani, MD · University of California, San Francisco

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-02-12
Primary Completion
2024-06-30
Completion
2024-08-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04311749 on ClinicalTrials.gov